RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation.

Abstract:

:The alternative nuclear factor-kappaB (NF-κB) -activation pathway proceeds via inducible p100 processing, leading to the activation of RelB-containing dimers. This pathway is aberrantly activated in several types of tumors; however, a direct role for RelB in the control of cell proliferation is still largely unexplored. Here, we demonstrate that RelB provides cell proliferation-inhibitory signals in murine fibroblasts. In agreement with these results, RelB ectopic expression inhibits xenograft tumor growth in vivo, whereas RelB knockdown enhances it. Significantly, we show that RelB inhibits cell proliferation and tumor growth in a p53-dependent manner. Mechanistic studies indicate that RelB regulates the transcription of the p53 tumor-suppressor gene through direct recruitment to the p53 promoter, thus increasing both p53 protein levels and expression of p53 target genes such as p21. Our findings define a novel link between NF-κB and growth-inhibitory pathways involving the RelB-dependent transcriptional upregulation of p53. Furthermore, they suggest that inhibition of RelB in some tumor types that retain wild-type p53 may diminish rather than improve therapeutic responses.

journal_name

Oncogene

journal_title

Oncogene

authors

Jacque E,Billot K,Authier H,Bordereaux D,Baud V

doi

10.1038/onc.2012.282

subject

Has Abstract

pub_date

2013-05-23 00:00:00

pages

2661-9

issue

21

eissn

0950-9232

issn

1476-5594

pii

onc2012282

journal_volume

32

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • S6K1 determines the metabolic requirements for BCR-ABL survival.

    abstract::In chronic myelogenous leukemia, the constitutive activation of the BCR-ABL kinase transforms cells to an addicted state that requires glucose metabolism for survival. We investigated S6K1, a protein kinase that drives glycolysis in leukemia cells, as a target for counteracting glucose-dependent survival induced by BC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.70

    authors: Barger JF,Gallo CA,Tandon P,Liu H,Sullivan A,Grimes HL,Plas DR

    更新日期:2013-01-24 00:00:00

  • A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27.

    abstract::Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related mortality in the United States. Exploring the mechanism of HCC and identifying ideal targets is critical. In the present study, we demonstrated metabolism dysfunction might be a key diver for the development of HCC. The mitochondrial amidoxime...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01417-6

    authors: Wu D,Wang Y,Yang G,Zhang S,Liu Y,Zhou S,Guo H,Liang S,Cui Y,Zhang B,Ma K,Zhang C,Liu Y,Sun L,Wang J,Liu L

    更新日期:2020-09-01 00:00:00

  • Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.

    abstract::Ki-1 lymphoma is a subtype of human malignant lymphoma characterized by the expression of CD30 (Ki-1) and a peculiar morphology. It is occasionally accompanied by a unique reciprocal chromosomal translocation t(2;5)(p23;q35). A Ki-1 lymphoma cell line, AMS3, was established by maintaining biopsied tumor cells in SCID ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shiota M,Fujimoto J,Semba T,Satoh H,Yamamoto T,Mori S

    更新日期:1994-06-01 00:00:00

  • MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.

    abstract::The RNA-binding protein (RBP) RNPC1 is a target of the p53 family and forms a feedback regulatory loop with the p53 family proteins. The murine double minute-2 (MDM2) oncogene, a key negative regulator of p53, has a critical role in a variety of fundamental cellular processes. MDM2 expression is found to be regulated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.238

    authors: Xu E,Zhang J,Chen X

    更新日期:2013-04-25 00:00:00

  • PML protein isoforms and the RBCC/TRIM motif.

    abstract::PML is a component of a multiprotein complex, termed nuclear bodies, and the PML protein was originally discovered in patients suffering from acute promyelocytic leukaemia (APL). APL is associated with a reciprocal chromosomal translocation of chromosomes 15 and 17, which results in a fusion protein comprising PML and...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204765

    authors: Jensen K,Shiels C,Freemont PS

    更新日期:2001-10-29 00:00:00

  • CXCR7/CXCR4 heterodimer-induced histone demethylation: a new mechanism of colorectal tumorigenesis.

    abstract::Both chemokine receptors (CXCRs) 7 and 4 can facilitate immune cell migration and mediate a vast array of physiological and pathological events. Herein we report, in both human and animal studies, that these two CXCRs can form heterodimers in vivo and promote colorectal tumorigenesis through histone demethylation. Com...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0519-2

    authors: Song ZY,Wang F,Cui SX,Gao ZH,Qu XJ

    更新日期:2019-02-01 00:00:00

  • Rho guanine nucleotide exchange factor ARHGEF10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma.

    abstract::Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal human cancers, with 5-year patient survival rates of <5%. Activating mutations in KRAS are the predominant oncogenic drivers of PDAC but are accompanied by additional lower frequency genetic alterations. Our group previously identified the guanine ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0985-1

    authors: Joseph J,Radulovich N,Wang T,Raghavan V,Zhu CQ,Tsao MS

    更新日期:2020-01-01 00:00:00

  • Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.

    abstract::Cyclooxygenase-2 (COX-2) is involved in diverse processes such as inflammation, carcinogenesis and apoptosis. As COX-2 inhibitors interfere with these processes, inhibition of COX-2 has been suggested as a promising anticancer treatment. However, the role of COX-2 in modulation of apoptosis as well as the death pathwa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206837

    authors: Totzke G,Schulze-Osthoff K,Jänicke RU

    更新日期:2003-09-11 00:00:00

  • PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion.

    abstract::PIKE-A (phosphoinositide 3-kinases (PI 3)-kinase enhancer) is a ubiquitously expressed GTPase, which binds to and enhances protein kinase B (Akt) kinase activity in a guanine nucleotide-dependent manner. PIKE-A is one of the components of the CDK4 amplicon that is amplified in numerous human cancers. However, whether ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210290

    authors: Liu X,Hu Y,Hao C,Rempel SA,Ye K

    更新日期:2007-07-26 00:00:00

  • Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.

    abstract::In this study we have surveyed by immunoblotting the protein levels of Cyclin D1, D2, D3 and their catalytic partners, Cdk4 and Cdk6 in normal and transformed human cells. We found that all these proteins were differentially expressed in diploid cells derived from different tissues, in contrast to Cyclin E, Cyclin A a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tam SW,Theodoras AM,Shay JW,Draetta GF,Pagano M

    更新日期:1994-09-01 00:00:00

  • Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins.

    abstract::We have examined the possibility that the E7 proteins of the high-risk human papillomavirus (HPV) type 16 and 18 and the oncogenic adenovirus (Ad) type 12 E1A protein share the ability to down-regulate the expression of components of the antigen processing and presentation pathway, as a common strategy in the evasion ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203860

    authors: Georgopoulos NT,Proffitt JL,Blair GE

    更新日期:2000-10-05 00:00:00

  • G-proteins in growth and apoptosis: lessons from the heart.

    abstract::The acute contractile function of the heart is controlled by the effects of released nonepinephrine (NE) on cardiac adrenergic receptors. NE can also act in a more chronic fashion to induce cardiomyocyte growth, characterized by cell enlargement (hypertrophy), increased protein synthesis, alterations in gene expressio...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204275

    authors: Adams JW,Brown JH

    更新日期:2001-03-26 00:00:00

  • Delaying mitotic exit downregulates FLIP expression and strongly sensitizes tumor cells to TRAIL.

    abstract::Many of the current antitumor therapeutic strategies are based on the perturbation of the cell cycle, especially during mitosis. Antimitotic drugs trigger mitotic checkpoint activation, mitotic arrest and eventually cell death. However, mitotic slippage represents a major mechanism of resistance to these treatments. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.601

    authors: Sánchez-Pérez T,Medema RH,López-Rivas A

    更新日期:2015-01-29 00:00:00

  • Characterization of VIK-1: a new Vav-interacting Kruppel-like protein.

    abstract::Binding partners of the Src homology domains of Vav-1 were characterized by a two-hybrid screening of a Jurkat cell cDNA library. One of the isolated clones encoded a new protein named VIK that belongs to the Kruppel-like zinc-finger gene family. Genome mapping showed that a single gene positioned at chromosome 7q22.1...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208043

    authors: Houlard M,Romero-Portillo F,Germani A,Depaux A,Regnier-Ricard F,Gisselbrecht S,Varin-Blank N

    更新日期:2005-01-06 00:00:00

  • An E mu-BCL-2 transgene facilitates leukaemogenesis by ionizing radiation.

    abstract::Clonogenic murine B cell precursors are normally ultrasensitive to apoptosis following genotoxic exposure in vitro but can be protected by expression of an E mu-BCL-2 transgene. Such exposures are likely to be mutagenic. This in turn suggests that a level of in vivo genotoxic exposure that usually has minimal patholog...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202721

    authors: Gibbons DL,MacDonald D,McCarthy KP,Cleary HJ,Plumb M,Wright EG,Greaves MF

    更新日期:1999-07-01 00:00:00

  • Analysis of a variant Max sequence expressed in Xenopus laevis.

    abstract::Max is a small helix-loop-helix protein which forms heterodimers with members of the Myc protein family. Myc/Max heterodimers exhibit sequence-specific DNA binding with much greater affinity than Myc homodimers. The Xenopus laevis homologue of Max, XMax, is shorter than the equivalent mammalian protein. This differenc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tonissen KF,Krieg PA

    更新日期:1994-01-01 00:00:00

  • Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.

    abstract::Overexpression of the c-Jun proto-oncogene in MCF7 breast cancer cells results in a variety of phenotype changes related to malignant progression including increased motility and invasion. Concurrent with these phenotypic effects are changes in the expression of multiple gene targets. We previously demonstrated that e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205857

    authors: Briggs J,Chamboredon S,Castellazzi M,Kerry JA,Bos TJ

    更新日期:2002-10-10 00:00:00

  • Distinct conformations of p53 are observed at different stages of keratinocyte differentiation.

    abstract::p53 is a multifunctional protein that has been shown to inhibit the growth of transformed cells, arrest the cell cycle of normal cells, regulate gene transcription and influence cellular differentiation, apoptosis and senescence. This study was undertaken to determine if the expression of p53 in keratinocytes varied d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Spandau DF

    更新日期:1994-07-01 00:00:00

  • Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.

    abstract::Arg and c-Abl represent the mammalian member of the Abelson family of nonreceptor protein tyrosine kinases. The two proteins are composed of SH2, SH3, kinase and C-terminal domains. To examine Arg structure-function relationships we analysed a Gag-Arg fusion protein, analogous to the oncogenic Gag-Abl fusion protein o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mysliwiec T,Perego R,Kruh GD

    更新日期:1996-02-01 00:00:00

  • HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.

    abstract::Amplification of HER-2 oncogene was analysed in DNAs obtained from 291 primary human mammary carcinomas. 52/291 (18%) were found to contain amplified HER-2 oncogene. Moderate amplification (2- to 5-fold) was noted in 36/291 (12%). Thirteen tumors (4.5%) had a copy number of 5 to 10. A 10- to 20-fold and greater than 2...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zeillinger R,Kury F,Czerwenka K,Kubista E,Sliutz G,Knogler W,Huber J,Zielinski C,Reiner G,Jakesz R

    更新日期:1989-01-01 00:00:00

  • mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.

    abstract::Cancer cells harboring oncogenic BRaf mutants, but not oncogenic KRas mutants, are sensitive to MEK inhibitors (MEKi). The mechanism underlying the intrinsic resistance to MEKi in KRas-mutant cells is under intensive investigation. Here, we pursued this mechanism by live imaging of extracellular signal-regulated kinas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.16

    authors: Komatsu N,Fujita Y,Matsuda M,Aoki K

    更新日期:2015-11-05 00:00:00

  • Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain.

    abstract::Abundant levels of the hyperactive low molecular weight (LMW) forms of cyclin E contribute to deregulation of Cdk2 in breast tumors, but the mechanism through which they arise is not fully understood. Here, we explored the hypothesis that post-translational processing by a protease generates the LMW forms of cyclin E ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206166

    authors: Wang XD,Rosales JL,Magliocco A,Gnanakumar R,Lee KY

    更新日期:2003-02-06 00:00:00

  • DNA: leukemia's secret weapon of bone mass destruction.

    abstract::Interaction of tumour cells with their microenvironment impacts on all aspects of cancer, ranging from development through to treatment response. In this issue, Dvorak and colleagues(1) reveal a novel tumour/microenvironment relationship that may drive leukemia pathogenesis. Specifically, they find that leukemic cells...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2012.639

    authors: Tait S

    更新日期:2013-10-31 00:00:00

  • The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.

    abstract::The role of TGF-β signaling in tumorigenesis is paradoxical: it can be tumor suppressive or tumor promotional, depending on context. The metastatic regulator, Six1, was recently shown to mediate this switch, providing a novel means to explain this elusive 'TGF-β paradox'. Herein, we identify a mechanism by which Six1 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.11

    authors: Smith AL,Iwanaga R,Drasin DJ,Micalizzi DS,Vartuli RL,Tan AC,Ford HL

    更新日期:2012-12-13 00:00:00

  • FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.

    abstract::Prostate cancer (PCa) growth is dependent on androgens and on the androgen receptor (AR), which acts by modulating gene transcription. Tetratricopeptide repeat (TPR) proteins (FKBP52, FKBP51 and Cyp40) interact with AR in PCa cells, suggesting roles in AR-mediated gene transcription and cell growth. We report here tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.458

    authors: Periyasamy S,Hinds T Jr,Shemshedini L,Shou W,Sanchez ER

    更新日期:2010-03-18 00:00:00

  • Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events.

    abstract::Chronic infection by hepatitis C virus (HCV) is a major risk factor for the onset and development of hepatocellular carcinoma (HCC), although the underlying mechanisms are unclear. The c-Myc oncogene contributes to the genesis of many types of cancers, including HCC, partly via the induction of genetic damage and the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.484

    authors: Higgs MR,Lerat H,Pawlotsky JM

    更新日期:2013-09-26 00:00:00

  • Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein.

    abstract::Cell cycle checkpoints and tumor suppressor gene functions appear to be required for the maintenance of a stable genome in proliferating cells. In this study chromosomal destabilization was monitored in relation to telomere structure, lifespan control and G2 checkpoint function. Replicative senescence was inactivated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201711

    authors: Filatov L,Golubovskaya V,Hurt JC,Byrd LL,Phillips JM,Kaufmann WK

    更新日期:1998-04-09 00:00:00

  • The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.

    abstract::A recent large multi-centre study convincingly confirmed previous observations that the SYT-SSX1 fusion type, compared to SYT-SSX2, of synovial sarcoma is associated with a worse clinical outcome. Apart from the clinical impact, this fact also suggests (1) that the SYT-SSX fusion gene may influence molecular mechanism...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205700

    authors: Xie Y,Skytting B,Nilsson G,Grimer RJ,Mangham CD,Fisher C,Shipley J,Bjerkehagen B,Myklebost O,Larsson O

    更新日期:2002-08-22 00:00:00

  • A 19S proteasomal subunit cooperates with an ERK MAPK-regulated degron to regulate accumulation of Fra-1 in tumour cells.

    abstract::Fos-related antigen-1 (Fra-1) is a member of the Activator Protein-1 (AP-1) transcription factor superfamily that is overexpressed in a variety of cancers, including colon, breast, lung, bladder and brain. High Fra-1 levels are associated with enhanced cell proliferation, survival, migration and invasion. Despite its ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.375

    authors: Pakay JL,Diesch J,Gilan O,Yip YY,Sayan E,Kolch W,Mariadason JM,Hannan RD,Tulchinsky E,Dhillon AS

    更新日期:2012-04-05 00:00:00

  • Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.

    abstract::Expression of neurotrophin receptors of the tyrosine kinase receptor (Trk) family is an important prognostic factor in solid tumors including neuroblastoma. High expression of TrkA (NTRK1) is associated with a favorable biology and outcome of neuroblastoma, whereas TrkB (NTRK2) is expressed on aggressive neuroblastoma...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208000

    authors: Schulte JH,Schramm A,Klein-Hitpass L,Klenk M,Wessels H,Hauffa BP,Eils J,Eils R,Brodeur GM,Schweigerer L,Havers W,Eggert A

    更新日期:2005-01-06 00:00:00